ADAR and cancer: ADAR1-induced editing of lncRNA prostate cancer antigen 3 (PCA3) enhanced its ability of binding and suppressing PRUNE2 pre-mRNA, subsequently promoting cancer cell proliferation, adhesion and migration [108].